Michal Schnaider Beeri

8.7k total citations
237 papers, 6.1k citations indexed

About

Michal Schnaider Beeri is a scholar working on Psychiatry and Mental health, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Michal Schnaider Beeri has authored 237 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Psychiatry and Mental health, 86 papers in Physiology and 34 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Michal Schnaider Beeri's work include Dementia and Cognitive Impairment Research (91 papers), Alzheimer's disease research and treatments (43 papers) and Diet and metabolism studies (30 papers). Michal Schnaider Beeri is often cited by papers focused on Dementia and Cognitive Impairment Research (91 papers), Alzheimer's disease research and treatments (43 papers) and Diet and metabolism studies (30 papers). Michal Schnaider Beeri collaborates with scholars based in United States, Israel and Germany. Michal Schnaider Beeri's co-authors include Jeremy M. Silverman, James Schmeidler, Vahram Haroutunian, Ramit Ravona‐Springer, Hillel Grossman, Mary Sano, Dushyant P. Purohit, Michael A. Rapp, Shlomo Noy and Uri Goldbourt and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Michal Schnaider Beeri

228 papers receiving 6.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michal Schnaider Beeri United States	42	2.2k	2.1k	911	907	705	237	6.1k
Brenna Cholerton United States	36	2.9k 1.3×	1.4k 0.7×	1.1k 1.2×	930 1.0×	1.1k 1.5×	95	6.7k
Weili Xu Sweden	45	2.2k 1.0×	1.8k 0.9×	795 0.9×	804 0.9×	759 1.1×	203	6.7k
Jeremy M. Silverman United States	51	1.7k 0.8×	3.8k 1.8×	583 0.6×	526 0.6×	648 0.9×	168	7.9k
Jeffrey M. Burns United States	47	3.8k 1.7×	2.4k 1.2×	815 0.9×	396 0.4×	1.7k 2.4×	253	8.0k
Rachel A. Whitmer United States	45	2.8k 1.2×	2.9k 1.4×	1.1k 1.2×	1.7k 1.9×	694 1.0×	223	9.3k
Laura D. Baker United States	44	4.7k 2.1×	1.8k 0.9×	1.7k 1.8×	2.1k 2.3×	1.7k 2.4×	155	10.1k
Davide Seripa Italy	53	3.8k 1.7×	2.1k 1.0×	1.0k 1.1×	410 0.5×	1.7k 2.4×	225	9.6k
Elisa Brietzke Brazil	56	1.5k 0.7×	4.3k 2.1×	911 1.0×	545 0.6×	1.5k 2.2×	274	12.1k
Cristiano Capurso Italy	41	2.2k 1.0×	1.5k 0.7×	645 0.7×	466 0.5×	750 1.1×	121	5.3k
Christiane Reitz United States	40	3.7k 1.7×	2.4k 1.2×	1.3k 1.4×	501 0.6×	1.9k 2.7×	113	8.1k

Countries citing papers authored by Michal Schnaider Beeri

Since Specialization

Citations

This map shows the geographic impact of Michal Schnaider Beeri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal Schnaider Beeri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal Schnaider Beeri more than expected).

Fields of papers citing papers by Michal Schnaider Beeri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michal Schnaider Beeri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal Schnaider Beeri. The network helps show where Michal Schnaider Beeri may publish in the future.

Co-authorship network of co-authors of Michal Schnaider Beeri

This figure shows the co-authorship network connecting the top 25 collaborators of Michal Schnaider Beeri. A scholar is included among the top collaborators of Michal Schnaider Beeri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michal Schnaider Beeri. Michal Schnaider Beeri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Levine, Stephen Z., et al.. (2025). New-generation antidiabetic medications and dementia risk in older adults with type 2 diabetes: A retrospective cohort study. The Journal of Prevention of Alzheimer s Disease. 12(8). 100199–100199.

Lin, Hung‐Mo, Ramit Ravona‐Springer, Abigail Livny, et al.. (2025). Brain Signatures of Very Early Cognitive Decline in Asymptomatic Middle‐Aged Offspring of People With Alzheimer's Disease. International Journal of Geriatric Psychiatry. 40(3). e70060–e70060.

Lesman‐Segev, Orit H., Abigail Livny, Hung‐Mo Lin, et al.. (2024). Amyloid deposition and small vessel disease are associated with cognitive function in older adults with type 2 diabetes. Scientific Reports. 14(1). 2741–2741. 3 indexed citations

Fonseca, Luciana Mascarenhas, Michal Schnaider Beeri, Zoë Hawks, et al.. (2024). ATN blood biomarkers are related to digital cognitive assessment in type 1 diabetes. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 16(4). e70029–e70029. 1 indexed citations

Ravona‐Springer, Ramit, Yael Inbar, Hila Zelicha, et al.. (2024). Abdominal fat depots are related to lower cognitive functioning and brain volumes in middle‐aged males at high Alzheimer's risk. Obesity. 32(5). 1009–1022. 6 indexed citations

Soleimani, Laili, et al.. (2023). Association of depression dimensions with cognitive functioning in community‐dwelling oldest old adults of LifeAfter90 study. Alzheimer s & Dementia. 19(S18). e079455–e079455. 1 indexed citations

Cukierman‐Yaffe, Tali, Ramit Ravona‐Springer, Abigail Livny, et al.. (2023). A feasibility study of the combination of intranasal insulin with oral semaglutide for cognition in older adults with metabolic syndrome at high dementia risk- Study rationale and design. Mechanisms of Ageing and Development. 218. 111898–111898. 6 indexed citations

Beeri, Michal Schnaider, et al.. (2023). Decrease in Gait Speed Over Time Is Associated With Increase in Number of Depression Symptoms in Older Adults With Type 2 Diabetes. The Journals of Gerontology Series A. 78(8). 1504–1512. 6 indexed citations

Fonseca, Luciana Mascarenhas, Pia Kivisäkk, Zoë Hawks, et al.. (2023). Plasma Alzheimer’s disease biomarkers and intraindividual cognitive variability measured by ecological momentary assessment in adults with type 1 diabetes. Alzheimer s & Dementia. 19(S15). 1 indexed citations

10.

Buchman, Aron S., Sue E. Leurgans, Tianhao Wang, et al.. (2021). Motor function is the primary driver of the associations of sarcopenia and physical frailty with adverse health outcomes in community-dwelling older adults. PLoS ONE. 16(2). e0245680–e0245680. 19 indexed citations

11.

Soleimani, Laili, Ramit Ravona‐Springer, Hung‐Mo Lin, et al.. (2021). Specific Dimensions of Depression Have Different Associations With Cognitive Decline in Older Adults With Type 2 Diabetes. Diabetes Care. 44(3). 655–662. 18 indexed citations

12.

Lacy, Mary E., Paola Gilsanz, Chloe W. Eng, et al.. (2020). Recurrent diabetic ketoacidosis and cognitive function among older adults with type 1 diabetes: findings from the Study of Longevity in Diabetes. BMJ Open Diabetes Research & Care. 8(1). e001173–e001173. 13 indexed citations

13.

West, Rebecca, Abigail Livny, Ramit Ravona‐Springer, et al.. (2020). Higher BMI is associated with smaller regional brain volume in older adults with type 2 diabetes. Diabetologia. 63(11). 2446–2451. 15 indexed citations

14.

Ravona‐Springer, Ramit, Anna Alkelai, Eric Yu, et al.. (2020). Association of the CD2AP locus with cognitive functioning among middle-aged individuals with a family history of Alzheimer's disease. Neurobiology of Aging. 101. 50–56. 5 indexed citations

15.

Rotenstreich, Ygal, Ofira Zloto, Ido Didi Fabian, et al.. (2019). Association of brain structure and cognitive function with structural retinal markers in asymptomatic individuals at high risk for Alzheimer disease. Investigative Ophthalmology & Visual Science. 60(9). 1878–1878. 1 indexed citations

16.

Lacy, Mary E., Paola Gilsanz, Chloe W. Eng, et al.. (2019). Severe Hypoglycemia and Cognitive Function in Older Adults With Type 1 Diabetes: The Study of Longevity in Diabetes (SOLID). Diabetes Care. 43(3). 541–548. 81 indexed citations

17.

Livny, Abigail, Ramit Ravona‐Springer, Anthony Heymann, et al.. (2016). Long-term Variability in Glycemic Control Is Associated With White Matter Hyperintensities in APOE4 Genotype Carriers With Type 2 Diabetes. Diabetes Care. 39(6). 1056–1059. 29 indexed citations

18.

Cai, Weijing, Jaime Uribarri, Li Zhu, et al.. (2014). Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans. Proceedings of the National Academy of Sciences. 111(13). 4940–4945. 138 indexed citations

19.

Ravona‐Springer, Ramit, Anthony Heymann, James Schmeidler, et al.. (2014). The ApoE4 genotype modifies the relationship of long-term glycemic control with cognitive functioning in elderly with type 2 diabetes. European Neuropsychopharmacology. 24(8). 1303–1308. 15 indexed citations

20.

Greenbaum, Lior, Michael W. Lutz, Anthony Heymann, et al.. (2014). The TOMM40 poly-T rs10524523 variant is associated with cognitive performance among non-demented elderly with type 2 diabetes. European Neuropsychopharmacology. 24(9). 1492–1499. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact